Posts

Sidewinder Therapeutics Announces $137 Million Series B Financing for Bispecific ADC Development

on

SanegeneBio raises over $110M Series B after Lilly RNAi deal

on

Pelage Pharmaceuticals Raises $120M to Advance Hair Loss Regenerative Therapy to Phase 3 Trials

on

Kailera Raises $600 Million to Launch Global Phase III Program for Obesity Drug

on

Ansa Biotechnologies Raises $54.4M in Series B to Scale US DNA Synthesis Manufacturing

on

Fierce Biotech Fundraising Tracker '25: Avenzo adds $60M Series B; Ollin debuts with $100M

on

ARTBIO Raises $132M Series B to Advance Alpha Radiotherapy Pipeline and Manufacturing with Pb212

on

NUCLIDIUM Sees Copper Isotopes as Future of Radiopharmaceuticals, Raises CHF 79M to Advance Clinical Development

on

Regeneron Leads $66M Series B for Actio Biosciences’ Rare Disease Therapeutics

on